Therefore, a combined evaluation of both triglycerides and insulin levels may serve as a more sensitive biomarker for early metabolic syndrome in adults free of diabetes, with a higher risk for cancer mortality compared to other ISIs and each surrogate alone. The gene discussed is INS; the disease is cancer.